Given that serotonin is known to play roles in metabolic homeostasis and T2DM, these findings suggest that the well-established influence of TCF7L2 polymorphisms on the risk of T2DM may, at least in part, involve a serotonin-dependent pathway [41]. The gene discussed is TCF7L2; the disease is type 2 diabetes mellitus.